Agios Pharmaceuticals
AGIO
#4995
Rank
โ‚น152.64 B
Marketcap
โ‚น2,605
Share price
-0.64%
Change (1 day)
-3.56%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2025 (TTM): -โ‚น41.12 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น44.79 Million. In 2024 the company made an earning of -โ‚น39.69 Billion a decrease over its 2023 earnings that were of -โ‚น36.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น41.12 Billion3.61%
2024 -โ‚น39.69 Billion8.75%
2023 -โ‚น36.49 Billion0.63%
2022 -โ‚น36.27 Billion2.81%
2021 -โ‚น35.28 Billion10.58%
2020 -โ‚น31.9 Billion-18.41%
2019 -โ‚น39.1 Billion15.72%
2018 -โ‚น33.79 Billion12.99%
2017 -โ‚น29.91 Billion59.61%
2016 -โ‚น18.74 Billion69.32%
2015 -โ‚น11.07 Billion119.28%
2014 -โ‚น5.05 Billion39.22%
2013 -โ‚น3.63 Billion69.1%
2012 -โ‚น2.15 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.104 T-2,592.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.097 T-4,831.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น868.95 B-2,060.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-โ‚น12.87 Billion-70.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น81.39 B-283.62%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น63.31 B-242.83%๐Ÿ‡บ๐Ÿ‡ธ USA